Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 6,841-6,852 of 10,612

Drug study icon

CompletedNCT00129467

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugOver 18 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: Depression

Drug study icon

CompletedNCT04885257

Methylphenidate for Ptsd and Stroke Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 40 Years to 75 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Drug study icon

CompletedNCT00323947

Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 18 Years

Countries: United States
Sponsor: Boston Children's Hospital
Condition: ADHD

Drug study icon

CompletedNCT00025779

Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 5 Years to 14 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: ADHD

Drug study icon

CompletedNCT00015223

Methylphenidate in the Treatment of Cocaine Dependent people with Adult Attention Deficit Hyperactivity Disorder - 5

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHD, AddictionDrugFrom 21 Years to 50 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: ADHD, Addiction

Other study type icon

TerminatedNCT00247689

Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalFrom 21 Years to 50 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT00506285

Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Utah
Condition: ADHD

Drug study icon

CompletedNCT00136734

Methylphenidate Treatment for Cocaine Abuse and ADHD - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

Drug study icon

CompletedNCT02178995

Methylphenidate Treatment of Attention Deficits in Epilepsy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Kimford Jay Meador
Condition: ADHD

Drug study icon

TerminatedNCT01127503

Metyrosine (Demser®) for Psychotic Disorders in people with Velocardiofacial Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 16 Years to 65 Years

Countries: United States
Sponsor: Bausch Health Americas, Inc.
Condition: Schizophrenia

Other study type icon

CompletedNCT05195684

MGH Trauma-related Nightmares SDI Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDOtherFrom 18 Years to 60 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: PTSD

Other study type icon

CompletedNCT03633929

mHealth for Patient Self-Management of Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalOver 18 Years

Countries: United States
Sponsor: Biomedical Development Corporation
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.